News
Eli Lilly will pay up to $1.3bn for Superluminal Medicines to discover and progress small-molecule therapeutics for GPCR ...
Eli Lilly said will raise the UK list price of its weight-loss treatment Mounjaro by up to 170%, amid a White House push to get drugmakers to raise medicine prices in Europe to allow for pricecuts in ...
At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight-loss jab, through private prescriptions ...
People paying privately for weight-loss drug Mounjaro in the UK face a rise in the cost of the treatment after manufacturer ...
Novo Nordisks stock has tumbled from record highs after slashing its 2025 outlook, as fierce competition, leadership changes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results